Isolation, Identification, and Purification of Murine Thymic Epithelial Cells
August 8th, 2014
Here we describe an efficient method for isolation, identification, and purification of mouse thymic epithelial cells (TECs). The protocol can be utilized for studies of thymus function for normal T cell development, thymus dysfunction, and T cell reconstitution.
The overall goal of this procedure is to isolate, identify and purify thymic epithelial cells or tech. This is accomplished by first enzymatically, digesting and mechanically disrupting the thymus to dissociate the tech into a single cell suspension. Next, the tech can be analyzed by flow cytometry or enriched via a panning strategy.
Ultimately, thymic epithelial subsets can be purified by fluorescence activated cell sorting. This method can help answer many key questions in the field of T-cell development, such as, how do thymic epithelial cells promote thymic selection? What causes thymic dysfunction in aging animals and how can we achieve T-cell reconstitution in vitro?
The main advantages of this technique are the high recovery of variable emmic germa cells, the unbiased enrichment of the emmic epithelial cells, and the high purity that can ultimately be achieved by cell sorting. To isolate thymic stromal cells, first identify the thymus, which is just under the ribs and looks like two thin white lobes overlying the heart. Then disconnect the connective tissue surrounding the thymus and use curved serrated forceps to gently pull and remove the thymic lobes.
Place the lobes into a six well plate containing five milliliters of medium and trim any surrounding fat and connective tissue. Then transferred the trimmed lobes to a new well containing five milliliters of freshly prepared enzyme solution and use fine scissors to make small incisions in the tissue. Place the plate in a 37 degree Celsius incubator.
After 20 minutes, gently pipette the tissue up and down several times with a five milliliter pipette to dissociate the slurry into a single cell suspension. Collect the supernatant fraction in a 50 milliliter tube containing 10 milliliters of cold albumin rich buffer on ice to neutralize the enzymes. Then add 2.5 milliliters of enzyme solution to the remaining tissue.
Incubate the plate for 15 minutes. After that, gently agitate the tissue with a three milliliter syringe equipped with an 18 gene needle to break up any aggregates. Then transfer the to the collection tube.
Then add 2.5 milliliters of enzyme solution to the remaining tissue. Incubate the plate for 15 minutes. After the third incubation, repeat the mechanical agitation with a 20 5G needle.
After incubating the tissue for a final five to 10 minutes, transfer the supernatant to the collection tube for centrifugation to identify the recovered tech by flow cytometry Following standard antibody staining procedures, run the samples on a multi-parameter flow cytometer and analyze the data using the appropriate fax analysis software to enrich the tech further by the panning method. First, incubate the cells with the appropriate antibody for the enrichment. Next, add the cell suspension to a pre-coded panning plate and then swirl the plate and incubated at room temperature.
After 30 minutes, swirl the plate vigorously and then transfer the supernatant to a conical tube. Rinse the plate two times with fresh, medium, pooling the washes in the collection tube. Then after spinning down the cells, resuspend the pellet in five milliliters of fresh, medium and transfer the cell suspension to a new panning plate, collecting the cells after swirling and incubating as just demonstrated to further purify the enriched tech into their thymic cell subsets.
After labeling with the appropriate antibodies, sort the tech through a 100 micrometer nozzle by fluorescence activated cell sorting, collecting the cells in 30%volume per volume FBS in medium. In this representative gating strategy for identifying tech by flow cytometry the expression of epca, but not CD 45 by the tech can be observed. Thus, tech can be gated according to their ep, camm and CD 45 expression tech are comprised of cortical or CEC and medullary or mtech thymic epithelial subsets.
These subsets can be distinguished by the live 51 antibody, which recognizes G glutamyl amino peptidase expressed by ctec and the lectin UEA one, which binds to mtech both ctech and Mtech express MHC Class two on their surfaces. Although mtech can be further classified into mtech low and mtech high populations, depending on their level of MHC two expression, approximately eight times more tech can be recovered using the just demonstrated liase enzyme based protocol compared to a protocol with collagenase and disc space with about nine times 10 to the fifth, able to be recovered from just one mouse thymus to decrease the sorting time and to increase the viability of the recovered stromal cells. Panning can be used as just demonstrated to deplete the thymocytes sites compared to whole prepared thymus cells.
The proportion of tech increases from less than 0.5%to over 15%in the post enriched cell population. After panning, the proportions of the tech subsets are not altered, suggesting that neither subset is selectively lost during panning. Compared to the preen enrichment sample, the recovery rate of tech is about 85%After watching this video, you should have a good understanding of how to enrich themic germ cells from more thans by panic, as well as how to identify and purify more themic epithelial subsides by flow cytometry.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a method for the isolation, identification, and purification of mouse thymic epithelial cells (TECs). The protocol is designed to facilitate studies on thymus function, T cell development, and thymic dysfunction.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Thymus Function
Background
- Thymic epithelial cells play a crucial role in T cell development.
- Understanding TECs can provide insights into thymic selection processes.
- Thymic dysfunction is associated with aging and various diseases.
- Reconstitution of T cells is vital for therapeutic strategies.
Purpose of Study
- To isolate and purify TECs for detailed analysis.
- To investigate the mechanisms of thymic selection.
- To explore causes of thymic dysfunction in aging.
Methods Used
- Enzymatic digestion and mechanical disruption of the thymus.
- Flow cytometry for analysis of TECs.
- Panning strategy for enrichment of TECs.
- Fluorescence activated cell sorting for purification of TEC subsets.
Main Results
- Successful isolation and purification of TECs.
- Identification of key TEC subsets involved in T cell development.
- Insights into thymic selection mechanisms.
- Potential implications for T cell reconstitution therapies.
Conclusions
- The described method is effective for studying TECs.
- Findings contribute to understanding thymic function and dysfunction.
- Future research can build on this protocol to explore T cell development.
Frequently Asked Questions
Executive Industry Relevance
Isolating rare stromal populations like thymic epithelial cells enables mechanistic de-risking of T-cell development hypotheses and supports predictive confidence in immunotherapy target validation. This method provides a disease-relevant system for studying thymic selection and dysfunction, directly informing preclinical model design and translational biomarker discovery. By improving recovery and viability of rare cell subsets, it reduces biological ambiguity in early discovery and enhances portfolio triage decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of thymic epithelial cell function in T-cell commitment and selection pathways.
- Operational Value: Provides unbiased enrichment of rare TECs from murine thymus, increasing yield approximately eightfold over collagenase-based methods.
- Scientific Value: Supports biological de-risking by allowing multiparameter flow cytometry identification of cortical and medullary TEC subsets.
Screening & Assay Development
- Scientific Value: Generates purified TEC subsets suitable for downstream functional assays like gene expression profiling and Western blot.
- Operational Value: Reduces cell sorting time and minimizes viability loss through thymocyte depletion via panning prior to FACS.
- Operational Value: Enables standardized preparation of single-cell suspensions from thymic stroma for reproducible immunological assays.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant system modeling of thymic dysfunction in aging and immune reconstitution studies.
- Operational Value: Facilitates translational continuity from discovery to preclinical validation by providing purified TECs for in vitro T-cell reconstitution.
- Scientific Value: Enables mechanistic de-risking of targets involved in thymic selection and T-cell development pathways.
Pipeline & Workflow Integration
The method fits within the discovery biology to lead identification continuum by providing validated stromal inputs for immunological target assessment and mechanistic studies.
- Discovery Biology: Supports hypothesis testing of thymic epithelial roles in positive and negative T-cell selection through isolatable, analyzable subsets.
- Screening: Delivers assay-ready, purified TEC populations with enhanced recovery and reduced sorting time for compound or modulator screening.
- Analytics: Enables quantitative multiparameter flow cytometry and molecular profiling (PCR, Western blot) for objective comparison of TEC states.
- Translational Research: Connects to preclinical T-cell reconstitution models by providing purified TECs capable of supporting lymphoid development in vitro.
- Enterprise Reuse: Establishes a scalable, standardized workflow for isolating rare thymic stromal cells applicable across immunology and immunotherapy discovery programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in T-cell development models by enabling reliable isolation and characterization of rare TEC subsets.
- Operational Value: Improves reproducibility and scalability through enzymatic-mechanical dissociation and panning-based enrichment prior to FACS.
- Strategic Value: Reduces late-stage biological risk by improving target validation in thymus-dependent immunological pathways.
- Portfolio Impact: Supports risk-adjusted advancement decisions by providing mechanistic insights into thymic selection and stromal-immune crosstalk.
Implementation Considerations
- Requires expertise in enzymatic tissue dissociation, flow cytometry staining, and fluorescence activated cell sorting.
- Dependent on access to cell culture incubators, centrifuges, flow cytometers, and panning plates coated with appropriate substrates.
- Necessitates standardization of enzyme digestion times and mechanical agitation steps to ensure consistent single-cell suspension quality.
- Requires adaptation considerations when applying to different mouse strains, ages, or disease models affecting thymic cellularity and stromal composition.
- Practical limitations include the rarity of TECs necessitating enrichment steps and the need for careful viability maintenance during prolonged sorting.
